Detalhe da pesquisa
1.
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
N Engl J Med
; 386(6): 531-543, 2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910859
2.
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1423-1438, 2021 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33944913
3.
Calcium Hydroxylapatite Dermal Filler for Treatment of Dorsal Hand Volume Loss: Results From a 12-Month, Multicenter, Randomized, Blinded Trial.
Dermatol Surg
; 44(1): 75-83, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28562435
4.
Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1494-1495, 2021 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34189562
5.
Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial.
JAMA Netw Open
; 6(4): e239135, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099299
6.
Safety, Immunogenicity and Efficacy of NVX-CoV2373 in Adolescents in PREVENT-19: A Randomized, Phase 3 Trial.
medRxiv
; 2022 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172135
7.
The efficacy assessment of a self-administered immunotherapy protocol.
Int Forum Allergy Rhinol
; 6(2): 148-55, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26467843